Literature DB >> 33467748

Unravelling Genetic Factors Underlying Corticobasal Syndrome: A Systematic Review.

Federica Arienti1, Giulia Lazzeri1, Maria Vizziello1, Edoardo Monfrini1, Nereo Bresolin2, Maria Cristina Saetti1, Marina Picillo3, Giulia Franco2, Alessio Di Fonzo2.   

Abstract

Corticobasal syndrome (CBS) is an atypical parkinsonian presentation characterized by heterogeneous clinical features and different underlying neuropathology. Most CBS cases are sporadic; nevertheless, reports of families and isolated individuals with genetically determined CBS have been reported. In this systematic review, we analyze the demographical, clinical, radiological, and anatomopathological features of genetically confirmed cases of CBS. A systematic search was performed using the PubMed, EMBASE, and Cochrane Library databases, included all publications in English from 1 January 1999 through 1 August 2020. We found forty publications with fifty-eight eligible cases. A second search for publications dealing with genetic risk factors for CBS led to the review of eight additional articles. GRN was the most common gene involved in CBS, representing 28 out of 58 cases, followed by MAPT, C9ORF72, and PRNP. A set of symptoms was shown to be significantly more common in GRN-CBS patients, including visuospatial impairment, behavioral changes, aphasia, and language alterations. In addition, specific demographical, clinical, biochemical, and radiological features may suggest mutations in other genes. We suggest a diagnostic algorithm to help in identifying potential genetic cases of CBS in order to improve the diagnostic accuracy and to better understand the still poorly defined underlying pathogenetic process.

Entities:  

Keywords:  CBS; atypical parkinsonism; corticobasal degeneration; corticobasal syndrome; genetics

Year:  2021        PMID: 33467748      PMCID: PMC7830591          DOI: 10.3390/cells10010171

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  93 in total

1.  Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

Authors:  Mariely DeJesus-Hernandez; Ian R Mackenzie; Bradley F Boeve; Adam L Boxer; Matt Baker; Nicola J Rutherford; Alexandra M Nicholson; NiCole A Finch; Heather Flynn; Jennifer Adamson; Naomi Kouri; Aleksandra Wojtas; Pheth Sengdy; Ging-Yuek R Hsiung; Anna Karydas; William W Seeley; Keith A Josephs; Giovanni Coppola; Daniel H Geschwind; Zbigniew K Wszolek; Howard Feldman; David S Knopman; Ronald C Petersen; Bruce L Miller; Dennis W Dickson; Kevin B Boylan; Neill R Graff-Radford; Rosa Rademakers
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

2.  Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes.

Authors:  Daniela Galimberti; Kelly Bertram; Alessandra Formica; Chiara Fenoglio; Sara M G Cioffi; Andrea Arighi; Elio Scarpini; Carlo Colosimo
Journal:  J Alzheimers Dis       Date:  2016-05-04       Impact factor: 4.472

3.  Familial Creutzfeldt-Jakob disease with M232R mutation presented with corticobasal syndrome.

Authors:  Jung Geol Lim; Eungseok Oh; Sangmin Park; Yong-Sun Kim; Aeyoung Lee
Journal:  Neurol Sci       Date:  2014-12-17       Impact factor: 3.307

4.  Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations.

Authors:  Jennifer L Whitwell; Clifford R Jack; Matthew Baker; Rosa Rademakers; Jennifer Adamson; Bradley F Boeve; David S Knopman; Joseph F Parisi; Ronald C Petersen; Dennis W Dickson; Michael L Hutton; Keith A Josephs
Journal:  Arch Neurol       Date:  2007-03

5.  Corticobasal syndrome associated with the A9D Progranulin mutation.

Authors:  Salvatore Spina; Jill R Murrell; Edward D Huey; Eric M Wassermann; Pietro Pietrini; Jordan Grafman; Bernardino Ghetti
Journal:  J Neuropathol Exp Neurol       Date:  2007-10       Impact factor: 3.685

Review 6.  Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis.

Authors:  Zhiheng He; Andrew Bateman
Journal:  J Mol Med (Berl)       Date:  2003-08-19       Impact factor: 4.599

7.  The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.

Authors:  Amanda J Myers; Alan M Pittman; Alice S Zhao; Kristen Rohrer; Mona Kaleem; Lauren Marlowe; Andrew Lees; Doris Leung; Ian G McKeith; Robert H Perry; Chris M Morris; John Q Trojanowski; Christopher Clark; Jason Karlawish; Steve Arnold; Mark S Forman; Vivianna Van Deerlin; Rohan de Silva; John Hardy
Journal:  Neurobiol Dis       Date:  2006-12-15       Impact factor: 5.996

8.  Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics.

Authors:  Jennifer L Whitwell; Stephen D Weigand; Bradley F Boeve; Matthew L Senjem; Jeffrey L Gunter; Mariely DeJesus-Hernandez; Nicola J Rutherford; Matthew Baker; David S Knopman; Zbigniew K Wszolek; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Rosa Rademakers; Clifford R Jack; Keith A Josephs
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

9.  Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members.

Authors:  NiCole Finch; Matt Baker; Richard Crook; Katie Swanson; Karen Kuntz; Rebecca Surtees; Gina Bisceglio; Anne Rovelet-Lecrux; Bradley Boeve; Ronald C Petersen; Dennis W Dickson; Steven G Younkin; Vincent Deramecourt; Julia Crook; Neill R Graff-Radford; Rosa Rademakers
Journal:  Brain       Date:  2009-01-21       Impact factor: 13.501

View more
  5 in total

Review 1.  Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes-Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism.

Authors:  Patrycja Krzosek; Natalia Madetko; Anna Migda; Bartosz Migda; Dominika Jaguś; Piotr Alster
Journal:  Front Aging Neurosci       Date:  2022-02-09       Impact factor: 5.750

Review 2.  Tauopathies: new perspectives and challenges.

Authors:  Yi Zhang; Kai-Min Wu; Liu Yang; Qiang Dong; Jin-Tai Yu
Journal:  Mol Neurodegener       Date:  2022-04-07       Impact factor: 14.195

Review 3.  Neuropathology and emerging biomarkers in corticobasal syndrome.

Authors:  Shunsuke Koga; Keith A Josephs; Ikuko Aiba; Mari Yoshida; Dennis W Dickson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2022-06-13       Impact factor: 13.654

4.  Frequency and Longitudinal Course of Motor Signs In Genetic Frontotemporal Dementia.

Authors:  Sonja Schönecker; Francisco J Martinez-Murcia; Boris-Stephan Rauchmann; Nicolai Franzmeier; Catharina Prix; Elisabeth Wlasich; Sandra V Loosli; Katja Bochmann; Juan-Manuel Gorriz Saez; Robert Laforce; Simon Ducharme; Maria Carmela Tartaglia; Elizabeth Finger; Alexandre de Mendonça; Isabel Santana; Raquel Sanchez-Valle; Fermin Moreno; Sandro Sorbi; Fabrizio Tagliavini; Barbara Borroni; Markus Otto; Matthis Synofzik; Daniela Galimberti; Rik Vandenberghe; John van Swieten; Christopher Butler; Alexander Gerhard; Caroline Graff; Adrian Danek; Jonathan D Rohrer; Mario Masellis; James Rowe; Johannes Levin
Journal:  Neurology       Date:  2022-08-10       Impact factor: 11.800

Review 5.  Parkin beyond Parkinson's Disease-A Functional Meaning of Parkin Downregulation in TDP-43 Proteinopathies.

Authors:  Katarzyna Gaweda-Walerych; Emilia Jadwiga Sitek; Ewa Narożańska; Emanuele Buratti
Journal:  Cells       Date:  2021-12-01       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.